$2.18 0.01 (+0.46%)
2/10/2012 3:59 PM

Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Featured Broker Partners


Advertisement